Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

278
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
278
Allergic Reactions02:06

Allergic Reactions

26.3K
Overview
26.3K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.6K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

206
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
206

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness of Tezepelumab Versus Omalizumab in Patients with Severe Uncontrolled Allergic Asthma in Spain.

PharmacoEconomics - open·2026
Same author

Rescue Inhaler Overuse in Severe Asthma: A Real-World Study of Short-Acting β<sub>2</sub>-Agonist and Short-Acting Muscarinic Antagonist Use.

Biomedicines·2026
Same author

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026
Same author

Real-World Effectiveness of Tezepelumab Across T2 and Non-T2 Severe Asthma Phenotypes: A Multicenter Spanish Cohort Study.

Archivos de bronconeumologia·2026
Same author

A Multi-Compartment Cytological Approach to Severe Asthma Phenotyping: The BRISA Study (Biomedical Research in Severe Asthma).

Journal of asthma and allergy·2026
Same author

Inhalers and climate change: A sustainable approach to severe asthma management.

Respiratory medicine·2026

Related Experiment Video

Updated: Apr 29, 2026

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

1.8K

Shellfish Allergy: a Comprehensive Review.

María Pedrosa1, Teresa Boyano-Martínez2, Carmen García-Ara2

  • 1Allergy Department, Hospital La Paz Institute for Health Research (IdiPAZ), Paseo de la Castellana 261, 28046, Madrid, Spain. maria.pedrosa@idipaz.es.

Clinical Reviews in Allergy & Immunology
|May 30, 2014
PubMed
Summary

Shellfish allergy is rising, with tropomyosin identified as a key allergen. New hypoallergenic molecules offer a promising therapeutic approach for managing this growing concern.

Keywords:
Arginine kinaseMyosin light chainSarcoplasmic calcium-binding proteinShellfish allergyTropomyosin

More Related Videos

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

15.9K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K

Related Experiment Videos

Last Updated: Apr 29, 2026

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules
07:01

Zebrafish Animal Model for the Study of Allergic Reactions in Response to Tick Saliva Biomolecules

Published on: September 16, 2022

1.8K
Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE
07:10

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E sIgE

Published on: April 21, 2019

15.9K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

11.3K

Area of Science:

  • Immunology
  • Food Allergy Research
  • Molecular Allergology

Background:

  • Shellfish allergy prevalence is increasing globally.
  • Key shellfish allergens include tropomyosin, arginine kinase, sarcoplasmic calcium-binding protein, myosin light chain, and hemocyanin.
  • These allergens are primarily proteins involved in muscle contraction.

Purpose of the Study:

  • To review advances in shellfish allergen characterization.
  • To discuss the impact of processing on allergen stability.
  • To explore new therapeutic strategies for shellfish allergy.

Main Methods:

  • Characterization of B cell epitopes in tropomyosin.
  • Identification of novel shellfish allergens.
  • Analysis of allergen stability under processing conditions (thermal, peptic digestion, Maillard reactions).
  • Development of hypoallergenic molecules.

Main Results:

  • Tropomyosin B cell epitopes are well-characterized.
  • Proteins like arginine kinase and sarcoplasmic calcium-binding protein are identified as allergens.
  • Some shellfish allergens exhibit thermal stability and resistance to digestion.
  • Recombinant hypoallergenic tropomyosin has been developed.
  • Cross-reactivity with invertebrates, including house dust mites, is common.

Conclusions:

  • Understanding shellfish allergens is crucial for diagnosis and treatment.
  • Processing methods can affect allergenicity, but some allergens remain stable.
  • Hypoallergenic molecules, like recombinant tropomyosin, represent a novel therapeutic avenue.
  • Widespread panallergens contribute to cross-reactivity, complicating management.